Earnings PerformanceTKNO posted Q4 revenues below analyst expectations, indicating potential struggles in achieving future profitability.
Funding EnvironmentDemand for TKNO's business is closely tied to biotech funding, which is currently constrained, potentially affecting future order volumes.
Valuation ConcernsThe stock of TKNO is currently trading at a premium compared to its small cap peers, which may limit its upside potential.